Theses›Healthcare & bio›Connectomics tooling

Connectomics tooling

Does the neural-data-acquisition + connectomics-tooling layer become a fundable horizontal picks-and-shovels market under brain-algorithm AI, or do the application companies integrate it away?

  • Bear
  • Early

The callMapping brains gets 100x cheaper, but the buyer is a fixed grant budget; until AI or pharma pays for brains there is no venture market here.

D1D2R1R2R3C1foragainst D1D2R1R2R3C1foragainst
Fig. 1The balance. Drivers and catalysts against restraints, each block sized by its weight; catalysts hang dashed because they have not happened yet, sized by their odds. It tips toward the restraints.
  1. D1A new cohort wants to build AI from brain algorithms, and brain-disease drug discovery wants the same wiring diagrams, at a scale labs have never produced.
  2. D2Barcoded neurons, expansion microscopy on light microscopes and self-proofreading AI claim a 100x cut in whole-brain cost, which was mostly proofreading.
  3. R1Demand is grant and philanthropic money, a fixed budget, so cheaper reconstruction buys more brain per dollar and not more dollars.
  4. R2The leading cost-cutter E11 Bio is a nonprofit, Zetta AI is NIH and SBIR funded, Google open-sourced its reconstruction tools, and AI companies build acquisition in-house.
  5. R3Even after the cost falls, whole mouse brains are $60-100M a year worldwide, smaller than one enterprise software contract.
  6. C1The FY2027 NIH BRAIN Initiative appropriation replaces the expiring Cures Act money and keeps the grant buyer whole.Oct 2026
Rests onthe beliefs underneath
Supported by · confidence
What would prove itdated tests, open and resolved
20272028202920302031today1234567predictionswatch 20272028202920302031today1234567predictionswatch
Fig. 2Each ring is a dated test: dashed while open, struck through when overdue, ticked or crossed once resolved.
  1. 1By end-2027 at least one VC-backed structural-connectomics or neural-data-acquisition tooling company closes a round >=$10M with brain-algorithm-AI (Flourish-class) or research customers named as the demand side.Dec 2027 · open
  2. 2A venture-backed connectomics tooling company raising $10M+ with AI or research customers named.Dec 2027 · open
  3. 3By end-2028, at least one VC-backed STRUCTURAL-connectomics or neural-data-acquisition tooling company raises a Series A >=$30M selling to AI or pharma data/compute customers.Dec 2028 · open
  4. 4By end-2028, at least one brain-algorithm AI company (Flourish-class) discloses buying external neural-data-acquisition or connectomics-reconstruction tooling/services rather than building fully in-house.Dec 2028 · open
  5. 5A $30M+ Series A with AI or pharma customers, or a brain-algorithm company disclosing it buys external tooling.Dec 2028 · open
  6. 6Connectomics reconstruction cost per mm3 of cortex falls >=10x between 2025 and 2030 vs the EM baseline, via barcoding/expansion/light-sheet + ML proofreading.Dec 2030 · open
  7. 7Reconstruction cost per cubic millimetre down 10x against the 2025 EM baseline.Dec 2030 · open
Expressionslisted, private, technologies
  • TMOThermo Fisher Scientific
    • full
     Sells volume electron-microscopy systems (plasma FIB-SEM, serial block-face imaging, array tomography) and acquisition software to life-science labs.
  • BRKRBruker
    • full
     Sells light-sheet microscopes for imaging cleared and expanded whole mouse brains, to neuroscience labs.
  • GOOGLGoogle (Connectomics team, Alphabet)
    • cheap
     Builds reconstruction pipelines in-house for connectome projects and releases the tools free as open source; sells nothing in this market.
Private · 5 private companies, 3 of them in the US.

Flourish · E11 Bio · Zetta AI · Connectome (NeuroTech) · MaxWell Biosystems

Technologies
Who has already bet on itprivate rounds, from public sources

$5M raised by 3 companies. Early: Little money in so far; a lead investor would set the pace.

  • $5MMaxWell Biosystems
    • Founded 2016
     Series A, Dec 2020 $5M (Sensirion, Venture Kick, existing shareholders and business angels)
  • ·Zetta AI Grant $1M · Venture Round
  • ·E11 Bio
    • Founded 2021
     Rounds not itemised
What changedthe record, newest first
  • 9 Jun 2026The smart way to play a brain-AI gold rush is the picks-and-shovels (the neural-data + connectomics tooling everyone needs), but right now the leading player is a nonprofit and the tools are open-source, so it is a space to watch with a sharp checklist, not yet a bet.
Reading
Show the reading